small molecule

ETHRANE

ENFLURANE

Loss of exclusivity—loss of exclusivity

CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand name	ETHRANE
Active ingredient	ENFLURANE
Strength	99.9% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	LIQUID
Route	INHALATION
Modality	Small molecule
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.